For decades, low- and no-calorie sweeteners have been marketed as the “silver bullet” for those looking to satisfy a sweet tooth without the metabolic consequences of traditional sugar. From the diet sodas cooling in office refrigerators to the sugar-free yogurts lining grocery store shelves, these additives have become an inescapable part of the modern, ultra-processed diet. However, a significant new study published in Neurology, the medical journal of the American Academy of Neurology, suggests that these convenient alternatives may carry a hidden, long-term cost for brain health.

The research, which tracked nearly 13,000 adults over eight years, indicates that individuals who consumed higher quantities of low- and no-calorie sweeteners experienced a notably faster decline in memory and executive thinking skills compared to those who avoided them. The findings are particularly concerning for individuals living with diabetes, who are often advised to prioritize these substances as part of their health management strategy.

A Deeper Look at the Sweetener Spectrum

Researchers at the University of São Paulo in Brazil set out to investigate the cognitive implications of seven specific sweeteners: aspartame, saccharin, acesulfame-K, erythritol, xylitol, sorbitol, and tagatose. These compounds are ubiquitous in the contemporary food supply, frequently appearing in flavored waters, energy drinks, low-calorie desserts, and various processed snacks. Some, particularly sugar alcohols like sorbitol and xylitol, are also sold as standalone packets for personal use in coffee or home baking.

Dr. Claudia Kimie Suemoto, the study’s lead author and an expert at the University of São Paulo, noted that while these products are widely viewed as healthier alternatives to sugar, the data reveals a more complicated reality. “Low- and no-calorie sweeteners are often seen as a healthy alternative to sugar; however, our findings suggest certain sweeteners may have negative effects on brain health over time,” Dr. Suemoto stated.

It is critical to note that the study establishes a correlation rather than a definitive cause-and-effect relationship. Because the study was observational, researchers cannot conclusively state that the sweeteners directly cause neurological damage or trigger memory loss. However, the strength of the association warrants a serious re-evaluation of how these additives are viewed in the context of long-term cognitive wellness.

Tracking Cognitive Trajectories in Nearly 13,000 Adults

To arrive at these findings, the research team analyzed longitudinal data from 12,772 adults across Brazil. The cohort was middle-aged, with an average age of 52 at the start of the study, and participants were followed for approximately eight years to track changes in their health and mental acuity.

At the onset, each participant underwent a rigorous dietary assessment, completing detailed questionnaires regarding their consumption habits over the previous year. This data allowed the researchers to calculate an estimated daily intake of the seven sweeteners under investigation. The participants were then categorized into three distinct groups based on their consumption levels.

The disparity in intake was significant. Those in the lowest consumption group averaged a modest 20 milligrams per day (mg/day), while those in the highest tier averaged 191 mg/day. To put these figures into perspective, 191 milligrams of aspartame—one of the most common sweeteners studied—is roughly equivalent to the amount contained in a single can of diet soda. Among the seven substances, sorbitol, a sugar alcohol, recorded the highest average intake at 64 mg/day.

Throughout the eight-year period, the participants underwent cognitive assessments at three intervals: the beginning, middle, and end of the study. These tests were designed to measure essential mental functions, including verbal fluency (the speed at which a person can retrieve and articulate words), working memory (the ability to hold and manipulate information in the short term), and overall cognitive processing speed.

Significant Findings: The 62% Gap

The results of the study were striking. Even after adjusting for a wide range of variables that are known to influence cognitive health—including age, biological sex, high blood pressure, and cardiovascular disease—the researchers found a clear divergence between the high-consumption and low-consumption groups.

Participants who fell into the highest consumption category exhibited a 62% faster rate of decline in their overall thinking and memory abilities compared to those in the lowest category. To translate this into clinical terms, the researchers estimated that this gap was equivalent to approximately 1.6 additional years of cognitive aging over the course of the study.

The trend was not limited to those consuming the highest amounts. Even moderate users of these sweeteners showed measurable signs of decline. Participants in the middle consumption tier experienced a 35% faster rate of decline compared to those with the lowest intake, which amounted to roughly 1.3 additional years of cognitive aging.

While these metrics describe changes in performance on standardized cognitive tests rather than a biological measurement of physical brain atrophy, the consistency of the results across the cohort provides a compelling reason for concern. It is important to reiterate that these statistics represent statistical trends; they do not imply that every person who uses artificial sweeteners will inevitably suffer from memory loss or cognitive impairment.

Age and Diabetes as Critical Variables

The study further refined its analysis by looking at demographic and health-related subgroups, revealing that the negative association with sweeteners was not uniform across all participants.

When the researchers segmented the data by age, they found that the link between high sweetener consumption and cognitive decline was most prominent in adults younger than 60. In this younger demographic, higher intake was specifically tied to a swifter deterioration in verbal fluency and overall cognitive performance. Interestingly, researchers did not observe a similar correlation in participants aged 60 and older, suggesting that the impact of these sweeteners may be mediated by age-related biological factors.

Perhaps most significantly, the relationship was markedly stronger in individuals with diabetes. This finding is of particular public health interest, as patients diagnosed with diabetes are frequently encouraged—or feel compelled—to adopt sugar substitutes as a primary strategy for glycemic control. Given that this population is already at higher risk for various complications, the potential for an additional layer of cognitive risk requires urgent further investigation.

When the researchers isolated the seven sweeteners to see if individual substances were responsible for the findings, they discovered that six of them—aspartame, saccharin, acesulfame-K, erythritol, sorbitol, and xylitol—were each associated with accelerated cognitive decline. Tagatose was the only exception, showing no statistically significant association with cognitive impairment in this study. However, the authors were quick to clarify that this does not necessarily mean tagatose is safe or neuroprotective; it simply suggests that the evidence in this specific dataset was insufficient to link it to the same negative outcomes.

Navigating the Future of Sugar Alternatives

The results of this study pose a difficult question for consumers and health professionals alike: if replacing sugar with low-calorie alternatives does not necessarily yield the expected health benefits, what are the alternatives?

Dr. Suemoto emphasized the complexity of the issue, noting that while the link to cognitive decline was observed in both healthy individuals and those with diabetes, the latter group is far more reliant on these substitutes. She underscored the necessity for more robust research to confirm these findings and to explore whether other, more natural sugar alternatives—such as honey, maple syrup, coconut sugar, or even fruit-based sweeteners like applesauce—could serve as more effective or safer options for the brain.

Despite the clear findings, the researchers acknowledged several limitations inherent in their methodology. Because the study was based on observational data and self-reported dietary recalls, there is a margin of error. Participants may have forgotten specific food items, underestimated portion sizes, or inaccurately reported their eating habits, which could influence the precision of the intake estimates. Furthermore, because it is an observational study, it is impossible to fully rule out the influence of other lifestyle or environmental factors that might independently affect cognitive health.

As the scientific community continues to grapple with the long-term effects of ultra-processed food additives, this study serves as a critical call to action. It highlights the need for larger, controlled clinical trials to determine whether these sweeteners play a direct role in brain function and to uncover the mechanisms behind why certain groups appear more vulnerable.

Supported by the Brazilian Ministry of Health, the Ministry of Science, Technology, and Innovation, and the National Council for Scientific and Technological Development, this research marks a significant step toward understanding the long-term health trade-offs inherent in the modern diet. For now, the study suggests that while sugar substitutes offer a path to lower caloric intake, they may not be the risk-free solution they were once thought to be, prompting a more cautious approach to their consumption.